S (2000-2009)

*older Articles in Pre-2000 List

SAFETY AS A MEDICINE*
SAFETY-ADULTERANTS / CONTAMINANTS*
SCHISTOSOMA INFECTION
SCHIZOPHRENIA / MENTAL DISORDERS*
SCLERODERMA
SEBACEOUS GLANDS  (Produce Skin Oils)
SEPTIC SHOCK / SEPSIS*
SICKLE CELL DISEASE
SINUSITIS
SLEEP APNEA
SLEEP MODULATION*
SMALLPOX  (See Also COW POX [not good news])
SMELL / ODOR DETECTION
SMOKED CANNABIS AS A MEDICATION* (See Also METHODS OF USE-SMOKING)
SOCIAL ADJUSTMENT / BEHAVIOR*
SPASTICITY*
SPINAL CORD INJURY*
SPINOCEREBELLAR ATAXIA / SCA (See ATAXIA)
SPLEEN*
SPORTS (See EXERCISE)
STEM CELLS
STIFF-PERSON SYNDROME / HYPEREKPLEXIA DISEASE
STRESS (See Also ANXIETY, POST TRAUMATIC STRESS DISORDER)
STORAGE of CANNABIS*
STROKE* (See Also PERINATAL HYPOXIC-ISCHEMIC INJURY)
STUTTERING
SUICIDE


SAFETY AS A MEDICINE
What is the lethal dose of marijuana? (news–undated) http://druglibrary.org/schaffer/library/mj_overdose.htm
The Science of Marijuana (book–2000) http://www.green215.com/sites/all/files/education_articles/Science%20Cannabis.pdf
Two hundred and thirteen cases of marijuana toxicoses in dogs (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed?term=Caroline%20W.%20Donaldson
The good and the bad effects of trans-delta-9-tetrahydrocannabinol (Δ9-THC) on humans  abst–2004) http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TCS-4CSG2C4-2&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=99df29b0ce94c395c01f5aad8825d28b
Long-term effects of exposure to cannabis (abst–2005) http://www.sciencedirect.com/science/article/pii/S1471489204001973
top
Adverse effects of medical cannabinoids: a systematic review (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2413308/
Merck Manual – Marijuana (Cannabis) (excerpt–2008) http://www.merckmanuals.com/professional/special_subjects/drug_use_and_dependence/marijuana_cannabis.html?qt=marijuana&alt=sh
Merck Manual – Marijuana (Cannabis) Consumer version (excerpt-2008) http://www.merckmanuals.com/home/special-subjects/drug-use-and-abuse/marijuana
How Safe Are Medical Cannabinoids? (news–2008) http://www.medicalnewstoday.com/releases/111442.php
Medical use of cannabinoids does not cause an increase in serious adverse health effects (news-2008) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=272
Report: Marijuana Less Harmful than Alcohol or Tobacco (news–2008) http://www.drugfree.org/join-together/other/report-marijuana-less
Medicines derived from cannabis: A review of adverse events (news–2008) http://www.news-medical.net/news/2008/06/16/39254.aspx
Claims Linking Health Problems And The Strength Of Cannabis May Be Exaggerated (news–2008) http://www.sciencedaily.com/releases/2008/06/080617125751.htm
Alcohol and cannabis use as risk factors for injury – a case-crossover analysis in a Swiss hospital emergency department (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654886/?tool=pubmed
Deaths from Marijuana v. 17 FDA-Approved Drugs (Jan. 1, 1997 to June 30, 2005) (report-2009) http://medicalmarijuana.procon.org/view.resource.php?resourceID=145
Harms associated with psychoactive substances: findings of the UKNational Drug Survey (abst–2009) http://www.unboundmedicine.com/medline/ebm/record/19939875/full_citation/Harms_associated_with_psychoactive_substances:_findings_of_the_UK_National_Drug_Survey_
Health Risks of Marijuana Still Not Nailed Down (news–2009) http://www.medpagetoday.com/Psychiatry/Addictions/16456
Cannabis, Tobacco and Alcohol Use in Canada (news–2009) http://www.heretohelp.bc.ca/visions/cannabis-vol5/cannabis-tobacco-and-alcohol-use-in-canada
Four percent of adults worldwide using cannabis (news–2009) http://phys.org/news174892348.html
Tobacco-Related Health Costs: $800; Booze-Related Health Costs: $165; Pot-Related Health Costs: $20 – Any Questions? (news–2009) http://www.huffingtonpost.com/paul-armentano/tobacco-related-health-co_b_362539.html
Marijuana-Related Health Costs Minimal Compared To Those Of Alcohol, Tobacco (news-2009) http://www.norml.org/index.cfm?Group_ID=8022
The FDA has written documentation that patients can overdose on Marinol and that it can be lethal (news–2009) http://www.examiner.com/examiner/x-19678-Cannabis-Revolution-Examiner~y2009m10d23-The-FDAhas-written-documentation-that-patients-can-overdose-on-Marinol-and-that-it-can-be-lethal


SAFETY – ADULTERANTS / CONTAMINANTS
Dust in the wind: the growing use of embalming fluid among youth in Hartford, CT (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16040367
When the drug of choice is a drug of confusion: embalming fluid use in inner city Hartford, CT (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16275635
top
Beliefs and social norms about cigarettes or marijuana sticks laced with embalming fluid and phencyclidine (PCP): why youth use “fry” (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15830737
An evaluation of the quality of medicinal grade cannabis in the Netherlands (full-2006) http://www.cannabis-med.org/english/journal/en_2006_01_1.pdf
Chemical content of street cannabis (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16710141
CONTAMINATION OF HERBAL OR ‘SKUNK-TYPE’ CANNABIS WITH GLASS BEADS (full–2007) http://www.dhsspsni.gov.uk/hss_md_3-2007.pdf
Letter: The herbal way – a response to Ethan Russo (letter–2007) http://www.cannabis-med.org/data/pdf/en_2007_03_1.pdf
Adulteration of cannabis with tobacco, calamus, and other cholinergic compounds (full-2008) http://www.cannabis-med.org/english/journal/en_2008_04_2.pdf
Invasive Pulmonary Aspergillosis Associated With Marijuana Use in a Man With Colorectal Cancer (full–2008) http://jco.ascopubs.org/cgi/content/full/26/13/2214?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&searchid=1&FIRSTINDEX=3520&resourcetype=HWCIT
Lead poisoning due to adulterated marijuana in Leipzig (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696942/?tool=pmcentrez
The use of fry (embalming fluid and PCP-laced cigarettes or marijuana sticks) among crack cocaine smokers (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873769/pdf/nihms195654.pdf
Ammonia release from heated ‘street’ cannabis leaf and its potential toxic effects on cannabis users (abst–2008) http://www.unboundmedicine.com/medline/ebm/record/18705690/abstract/Ammonia_release_from_heated_%27street%27_cannabis_leaf_and_its_potential_toxic_effects_on_cannabis_users_
Neuropsychological effects of formaldehyde use (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18720671
Cannabis potency and contamination: a review of the literature (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18494838
Sildenafil analogs used for adulterating marihuana (abst–2008) http://www.fsijournal.org/article/S0379-0738%2808%2900363-0/abstract
Smoke Pot, Get Lead Poisoning? (Germany/Europe) (news–2008) http://www.webmd.com/news/20080409/smoke-pot-get-lead-poisoning
Latest cannabis contamination – homosildenafil and thiohomosildenafil (AKA Viagra) (news-2008) http://ukcia.org/wordpress/?p=39
Respiratory consequences of inhalation of adulterated cannabis (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19543175


SCHISTOSOMA INFECTION
Endocannabinoids anandamide and its cannabinoid receptors in liver fibrosis after murine schistosomiasis (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19399401


SCHIZOPHRENIA / MENTAL DISORDERS
Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/11204352
Are Cannabinoid Receptor Knockout Mice Animal Models for Schizophrenia? (abst-2000) http://www.medical-hypotheses.com/article/S0306-9877%2800%2991261-1/abstract
top
Cannabis Use is Not Associated with the Development of Psychosis in an ‘ultra’ High-risk Group (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12406123
Tobacco and Cannabis Smoking Cessation Can Lead to Intoxication with Clozapine or Olanzapine (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/11981356
Marijuana receptor gene abnormality in schizophrenia (news–2002) http://www.eurekalert.org/pub_releases/2002-07/mp-mrg061802.php
Cannabis may treat psychiatric disorders (news–2002) http://www.highbeam.com/doc/1G1-90446996.html
Recipe For Trouble (anecdotal/ news–2002) http://www.cbsnews.com/stories/2002/03/05/48hours/main503022.shtml
Cannabis and the brain (full-2003) http://brain.oxfordjournals.org/cgi/content/full/126/6/1252
Haloperidol, but not clozapine, produces dramatic catalepsy in delta9-THC-treated rats: possible clinical implications (full–2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574061/?tool=pubmed
Endocannabinoid signalling in the blood of patients with schizophrenia (full–2003) http://www.lipidworld.com/content/2/1/5
Aetiology – Review: current evidence does not show a strong causal relation between the use of cannabis in young people and psychosocial harm (full–2004) http://ebmh.bmj.com/content/7/4/119.long
Cannabis as a psychotropic medication (letter–2004) http://bjp.rcpsych.org/cgi/content/full/185/1/78
Lower Negative Symptom Scores Among Cannabis-dependent Patients with Schizophrenia-spectrum Disorders: Preliminary Evidence from an African American First-episode Sample (abst–2004) http://www.schres-journal.com/article/S0920-9964%2804%2900035-0/abstract
How our brains fend off madness, we produce a cannabis like substance (news–2004) http://www.medicalnewstoday.com/releases/12516.php
Cannabis does not induce schizophrenia, Dutch scientists say (news–2004) http://www.medicalnewstoday.com/articles/12283.php
Symptoms of schizotypy precede cannabis use (full–2005) http://socialsciences.people.hawaii.edu/publications_lib/Cannabis%20and%20SPD.pdf
On the Cannabinoid Receptor: A Study in Molecular Psychiatry (full – 2005) (needs free registration) http://www.psychiatrictimes.com/articles/cannabinoid-receptor-study-molecular-psychiatry
Cannabis and schizophrenia link blurs further (news-2005) (needs registration) http://www.newscientist.com/channel/health/mg18624953.800-cannabis-and-schizophrenia-link-blursfurther.html
Chemicals in Cannabis may help mentally ill (news–2005) http://www.news-medical.net/news/2005/06/06/10716.aspx
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug (full–2006) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000400001&lng=en&nrm=iso&tlng=en
Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction (full–2006) http://www.ukcia.org/research/COMTgene.pdf
The Mental Health Risks of Adolescent Cannabis Use (full–2006) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1351917&tool=pmcentrez
An Experimental Study of Catechol-O-Methyltransferase Val(158)Met Moderation of Delta-9-Tetrahydrocannabinol-Induced Effects on Psychosis and Cognition (full-2006) http://www.nature.com/npp/journal/v31/n12/full/1301197a.html
Cannabis and psychosis (letter–2006) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1360440&tool=pmcentrez
Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. (abst-2006) http://www.ncbi.nlm.nih.gov/pubmed/16710682
top
Cannabis use does not cause schizophrenia (news–2006) http://www.health.am/psy/more/cannabis_use_does_not_cause_schizophrenia/
No Increased Schizophrenia Risk With Use Of Cannabis (news–2006) http://www.thehempire.com/index.php/cannabis/news/no_increased_schizophrenia_risk_with_use_of_cannabis
Cannabis is a First-Line Treatment for Childhood Mental Disorders (news-2006) http://www.counterpunch.org/2006/07/08/cannabis-is-a-first-line-treatment-forchildhood-mental-disorders/
Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use (full–2007) http://bjp.rcpsych.org/content/191/5/402.long
Reefer Madness Refuted (letter-2007) http://www.cmaj.ca/content/177/8/988.full.pdf+html
A Comparison of Symptoms and Family History in Schizophrenia with and Without Prior Cannabis Use: Implications for the Concept of Cannabis Psychosis (abst–2007) http://www.schres-journal.com/article/S0920-9964%2807%2900150-8/abstract
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use (abst–2007) http://www.unboundmedicine.com/medline/ebm/record/17566707/abstract/Anandamide_levels_in_cerebrospinal_fluid_of_first_episode_schizophrenic_patients:_Impact_of_cannabis_use
Cannabinoids and psychosis (abst–2007) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17349865&ordinalpos=185&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis (full–2008) http://bjp.rcpsych.org/cgi/content/full/192/4/306?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=1200&resourcetype=HWCIT
Neuronal and glial alterations in the cerebellar cortex of maternally deprived rats: gender differences and modulatory effects of two inhibitors of endocannabinoid inactivation (full–2008) http://onlinelibrary.wiley.com/doi/10.1002/dneu.20672/pdf
Gender-dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: a possible role for the endocannabinoid system (full–2008) http://onlinelibrary.wiley.com/doi/10.1002/dneu.20666/pdf
The effects of cannabis abuse on the symptoms of schizophrenia: patient perspectives (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18666905
Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18186055
Maternal tobacco, cannabis and alcohol use during pregnancy and risk of adolescent psychotic symptoms in offspring (full–2009) http://bjp.rcpsych.org/cgi/content/full/195/4/294
Cannabis and suicide: longitudinal study (full–2009) http://bjp.rcpsych.org/content/195/6/492.long
THC can improve symptoms of schizophrenia (article– 2009) http://www.cannabis-med.org/data/pdf/en_2009_04_1_0.pdf
Parasitic brain infection, endocannabinoids, and schizophrenia. (abst – 2009) http://www.unboundmedicine.com/medline/ebm/record/18995970/abstract/Parasitic_brain_infection_endocannabinoids_and_schizophrenia_
The role of cannabis in cognitive functioning of patients with schizophrenia (abst–2009)http://www.unboundmedicine.com/medline/ebm/record/19326102/abstract/The_role_of_cannabis_in_cognitive_functioning_of_patients_with_schizophrenia_
top
Cannabis use and deliberate self-harm in adolescence: a comparative analysis of associations in England and Norway (abst–2009) http://www.unboundmedicine.com/medline/ebm/record/19813111/abstract/Cannabis_use_and_deliberate_self_harm_in_adolescence:_a_comparative_analysis_of_associations_in_England_and_Norway_
Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia (abst–2009) http://www.unboundmedicine.com/medline/ebm/record/19891810/full_citation/Opposite_relationships_between_cannabis_use_and_neurocognitive_functioning_in_bipolar_disorder_and_schizophrenia_
Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania (abst–2009) http://jop.sagepub.com/content/25/2/274.abstract
Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia (abst–2009) http://www.unboundmedicine.com/medline/ebm/record/19440079/abstract/Synthetic_delta_9_tetrahydrocannabinol__dronabinol__can_improve_the_symptoms_of_schizophrenia_
Can recreational doses of THC produce significant dopamine release in the human striatum? (abst–2009) http://www.unboundmedicine.com/medline/ebm/record/19539765/full_citation/Can_recreational_doses_of_THC_produce_significant_dopamine_release_in_the_human_striatum
Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005 (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19560900
If cannabis caused schizophrenia-how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations (abst–2009)http://www.unboundmedicine.com/medline/ebm/record/19832786/full_citation/If_cannabis_caused_schizophrenia_how_many_cannabis_users_may_need_to_be_prevented_in_order_to_prevent_one_case_of_schizophrenia_England_and_Wales_calculations_
Minimal Relationship Between Cannabis And Schizophrenia Or Psychosis, Suggested By New Study (news-2009) http://www.sciencedaily.com/releases/2009/10/091022101538.htm
Marijuana: Help or hassle? (news–2009) http://www.heretohelp.bc.ca/visions/cannabis-vol5/marijuana-help-or-hassle
Schizophrenia link to cannabis denied (news–2009) http://www.thisisstaffordshire.co.uk/news/Schizophrenia-link-cannabis-denied/article-1288926-detail/article.html
Cannabis and smoking gene links to schizophrenia ‘unfounded’ (news–2009) http://www.medwirenews.com/47/71003/Psychiatry/Cannabis_and_smoking_gene_links_to_schizophrenia_%E2%80%98unfounded%E2%80%99.html
New study suggests minimal relationship between cannabis and schizophrenia or psychosis (news–2009) http://www.physorg.com/news175425054.html
Science: The development of the number of new schizophrenia cases in the UK does not support the hypothesis that cannabis use increases schizophrenia risk (news–2009) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=299
Maternal Marijuana use not Associated with Psychotic Symptoms , but Alcohol is (news–2009) http://ohiopatientsnetwork.org/index.php?option=com_content&view=article&id=85:marijuana-notassociated-with-psychotic-symptoms-but-alcohol-is&catid=3:newsflash
top


SCLERODERMA
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757311/?tool=pmcentrez
The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis (full-2009) http://onlinelibrary.wiley.com/doi/10.1002/art.24395/full
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts (full–2009) http://rheumatology.oxfordjournals.org/content/48/9/1050.full


SEBACEOUS GLANDS 
Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin (abst-2005) http://www.ncbi.nlm.nih.gov/pubmed/15927811
Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling (full–2008) http://www.fasebj.org/content/22/10/3685.long
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757311/
Sebaceous gland receptors (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835895/


SEPTIC SHOCK / SEPSIS
Endocannabinoid Degradation, Endotoxic Shock and Inflammation (link to PDF–2002) http://www.eurekaselect.com/91915/article
Presynaptic cannabinoid CB1 receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats (full–2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1575049/?tool=pmcentrez
Effects of AM281, a cannabinoid antagonist, on systemic haemodynamics, internal carotid artery blood flow and mortality in septic shock in rats (full–2005) http://bja.oxfordjournals.org/content/94/5/563.full
Cannabinoid antagonist AM 281 reduces mortality rate and neurologic dysfunction after cecal ligation and puncture in rats (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16276190
Effects of AM281, a cannabinoid antagonist, on circulatory deterioration and cytokine production in an endotoxin shock model: comparison with norepinephrine (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/17072693
Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB1 receptors and fatty acid amide hydrolase (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2008.01114.x/full
Effects of the cannabinoid antagonist AM281 on systemic hemodynamics and mortality rate in streptozotocin-induced diabetic rats with endotoxic shock: comparison between non-diabetic and diabetic rats (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18261198
Endocannabinoids and cardiac contractile function: pathophysiological implications (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768548/?tool=pubmed
top
The cannabinoid receptor 2 is critical for the host response to sepsis (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763235/?tool=pubmed


SICKLE CELL DISEASE
Cannabis use in sickle cell disease: a questionnaire study (abst–2005) http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=16173972&dopt=Abstract
Medical use of cannabis in sickle cell disease (news–2005) http://www.chanvre-info.ch/info/it/Medical-use-of-cannabis-in-sickle.html
The prevalence of marijuana smoking in young adults with sickle cell disease: a longitudinal study (full–2006) http://caribbean.scielo.org/scielo.php?script=sci_arttext&pid=S0043-31442006000400004&lng=en&nrm=iso
Marijuana Use Prevalent Among Sickle Cell Patients (news–2007) http://norml.org/index.cfm?Group_ID=7163
Marijuana Use and Sickle Cell Disease (abst–2008) http://abstracts.hematologylibrary.org/cgi/content/abstract/112/11/4826?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=1840&resourcetype=HWCIT
Cannabinoids as Analgesics for Pain in Sickle Cell Disease (abst–2009) http://abstracts.hematologylibrary.org/cgi/content/abstract/114/22/822?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=240&resourcetype=HWCIT


SINUSITIS
Medical Marijuana and Sinusitis (news-2009) https://www.marijuanadoctors.com/content/ailments/view/87?ailment=sinusitis


SLEEP APNEA
Functional role for cannabinoids in respiratory stability during sleep (link to PDF-2002) http://www.journalsleep.org/ViewAbstract.aspx?pid=25731
THC reduces sleep apnoea in animal research (news–2002) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=120#1
Medical Marijuana and Sleep Apnea (news–2009) https://www.marijuanadoctors.com/content/ailments/view/103?ailment=sleep-apnea


SLEEP MODULATION
Therapeutic aspects of cannabis and cannabinoids (full–2001) http://bjp.rcpsych.org/cgi/content/full/178/2/107
Functional role for cannabinoids in respiratory stability during sleep (link to PDF-2002) http://www.journalsleep.org/ViewAbstract.aspx?pid=25731
The cannabinoids R(-)-7-hydroxy-delta-6-tetra-hydrocannabinol-dimethylheptyl (HU-210), 2-O-arachidonoylglycerylether (HU-310) and arachidonyl-2-chloroethylamide (ACEA) increase isoflurane provoked sleep duration by activation of cannabinoids 1 (CB1)-receptors in mice (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12095655
Dreams, endocannabinoids and itinerant dynamics in neural networks: re elaborating Crick-Mitchison unlearning hypothesis (abst–2002) http://adsabs.harvard.edu/abs/2002cond.mat..8590K
Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/14746372?dopt=Abstract
top
Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early morning behavior in young adults (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15118485?dopt=Abstract
Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/14715144
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial (abst–2004) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=15
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis (abst–2005) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=175
Cannabinoids attenuate norepinephrine-induced melatonin biosynthesis in the rat pineal gland by reducing arylalkylamine N-acetyltransferase activity without involvement of cannabinoid receptors (full–2006) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2006.03873.x/pdf
Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16844117
The synthetic cannabinoid nabilone improves pain and symptom management in cancer patients (abst–2006) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=177
Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis based medicine (abst-2007) http://www.ncbi.nlm.nih.gov/pubmed/17712817
Neuropharmacological effects of oleamide in male and female mice (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17588682
Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep (abst-2007) http://marijuana.researchtoday.net/archive/4/8/1234.htm
Effects of different substance misuse in genital reflexes of paradoxical sleep deprived male rats (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17518911
Cannabinoids Associated With “More Restful Sleep,” Study Says (news–2007) http://www.illinoisnorml.org/content/view/648/27/
The nonpsychoactive cannabis constituent cannabidiol is a wake-inducing agent (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/19045957
Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18313952?dopt=AbstractPlus
The modulatory role of endocannabinoids in sleep (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18297624
The role of the CB1 receptor in the regulation of sleep (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18514375
Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757605/?tool=pubmed
The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD) (full–2009) http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2008.00071.x/full
Effects of central endocannabinoid system on visceral hyposensitivity induced by rapid eye movement sleep deprivation: experiment with rats (abst–2009) http://science.naturalnews.com/2009/1199881_Effects_of_central_endocannabinoid_system_on_visceral_hyposensitivity_induced_by.html
Sleep-inducing factors (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19689305
Medical Marijuana and Nightmares (news–2009) https://www.marijuanadoctors.com/content/ailments/view/47?ailment=nightmares
Medical Marijuana and Persistent Insomnia (news–2009) https://www.marijuanadoctors.com/content/ailments/view/52?ailment=persistent-insomnia
top
Medical Marijuana and Sleep Disorders (news–2009) https://www.marijuanadoctors.com/content/ailments/view/177?ailment=sleep-disorders


SMALLPOX
“Recreational” drug abuse associated with failure to mount a proper antibody response after a generalised orthopoxvirus infection (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17917699


SMELL / ODOR DETECTION
Marijuana Odor Perception (full–2004) http://norml.org/pdf_files/brief_bank/marijuanaodorstudy.pdf
Cannabinoid action in the olfactory epithelium (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1815290/?tool=pubmed
Essential oil of Cannabis sativa L. strains (full–2008) http://www.internationalhempassociation.org/jiha/jiha4208.html


SMOKED CANNABIS AS A MEDICATION
CANNABIS AND MARINOL IN THE TREATMENT OF MIGRAINE HEADACHE (full-undated) http://www.druglibrary.org/schaffer/hemp/migrn2.htm
Effects of smoked cannabis and oral d9-tetrahydrocannabinol on nausea and emesis after cancer chemotherapy (full–2001) http://www.cannabis-med.org/data/pdf/2001-01-2.pdf
Antiemetic efficacy of smoked marijuana: subjective and behavioral effects on nausea induced by syrup of ipecac (abst–2001) http://www.ncbi.nlm.nih.gov/pubmed/11509190?dopt=Abstract
The Role of Cannabis and Cannabinoids in Pain Management (full–2002) http://www.humanhemphealth.ca/Russo-AAPM_chapter.pdf
A Dramatic Response to Inhaled Cannabis in a Woman with Central Thalamic Pain and Dystonia (full-2002) http://www.jpsmjournal.com/article/PIIS0885392402004268/fulltext
Chronic Cannabis Use in the Compassionate Investigational New Drug Program (full-2002) http://www.maps.org/mmj/russo2002.pdf
Chronic Cannabis Use in the Compassionate Investigational New Drug Program (abstract & comments-2002) http://www.letfreedomgrow.com/cmu/chronic_cannabis_use.htm
The effects of smoked cannabis in painful peripheral neuropathy and cancer pain refractory to opiods (abst–2003) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=96
Study: Brain Not Permanently Damaged by Marijuana (news–2003) http://www.drugfree.org/join-together/drugs/study-brain-not-permanently
Marijuana Smoking Doesn’t Kill (news–2003) http://www.webmd.com/smoking-cessation/news/20030918/marijuana-smoking-doesnt-kill
Marijuana Smoking Doesn’t Lead to Higher Death Rate (news/forum repost–2003) http://www.420magazine.com/forums/medical-marijuana-facts-information/79280-marijuana-smokingdoesnt-lead-higher-death-rate.html
Epilepsy patients are smoking pot (news/ forum repost–2004) http://www.420magazine.com/forums/epilepsy/154906-epilepsy-patients-smoking-pot.html
Marinol vs Natural Cannabis (full–2005) http://www.norml.org/pdf_files/NORML_Marinol_vs_Natural_Cannabis.pdf
top
Smoked cannabis therapy for HIV-related painful peripheral neuropathy: results of a randomized, placebo-controlled clinical trial (abst–2005) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=172
Medical use of cannabis in sickle cell disease (news–2005) http://www.chanvre-info.ch/info/it/Medical-use-of-cannabis-in-sickle.html
Evaluation of herbal cannabis characteristics by medical users: a randomized trial (full–2006) http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17101054
The Cannabinoid Cb1 Receptor Antagonist Rimonabant Attenuates the Hypotensive Effect of Smoked Marijuana in Male Smokers (full–2006) http://www.ahjonline.com/article/S0002-8703%2805%2901013-6/fulltext
Marijuana smoking in young adults with sickle cell (news–2006) http://www.illinoisnorml.org/content/view/309/
Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689519/?tool=pubmed
Dose-dependent Effects of Smoked Cannabis on Capsaicin-Induced Pain and Hyperalgesia in Healthy Volunteers (full–2007) http://journals.lww.com/anesthesiology/Fulltext/2007/11000/Gabapentin_Suppresses_Cutaneous_Hyperalgesia.16.aspx
Cannabis in painful HIV-associated sensory neuropathy (full-2007) http://www.cmcr.ucsd.edu/images/pdfs/Abrams_2007.pdf
Dronabinol and marijuana in HIV-positive marijuana smokers: caloric intake, mood, and sleep (abst–2007) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=190
Fitness to drive in spite (because) of THC (abst–2007) http://www.unboundmedicine.com/medline/ebm/record/17879702/abstract/%5BFitness_to_drive_in_spite__because__of_THC%5D
Brain’s Fear Response Could Help Treat Pain And Anxiety (news–2007) http://www.alphagalileo.org/ViewItem.aspx?ItemId=16135&CultureCode=en
Study Supports Medical Marijuana Use (news–2007) http://www.drugfree.org/join-together/drugs/study-supports-medical
Smoked Cannabis Proven Effective In Treating Neuropathic Pain (news–2007) http://www.sciencedaily.com/releases/2007/10/071024141745.htm
Marijuana gives relief from chronic pain for AIDS sufferers (news–2007) http://www.news-medical.net/news/2007/02/14/21906.aspx
Smoked Cannabis Reduces Foot Pain Associated With HIV In Placebo Trial (news-2007) http://www.sciencedaily.com/releases/2007/02/070212185335.htm
Hypothesizing that marijuana smokers are at a significantly lower risk of carcinogenicity relative to tobacco-non-marijuana smokers: evidenced based on statistical reevaluation of current literature (full–2008) http://www.thefreelibrary.com/Hypothesizing+that+marijuana+smokers+are+at+a+significantly+lower…-a0196052086
A Randomized, Placebo Controlled Cross-Over Trial of Cannabis Cigarettes in Neuropathic Pain (full-2008) http://cmcr.ucsd.edu/images/pdfs/Wilsey_2008.pdf
Medicinal Marijuana Effective For Neuropathic Pain In HIV, Study Finds (news-2008) http://www.sciencedaily.com/releases/2008/08/080806113135.htm
Marijuana May Be Effective For Neuropathic Pain (news–2008) http://www.sciencedaily.com/releases/2008/06/080626150628.htm
Cannabinoid Receptor 1 Binding Activity and Quantitative Analysis of Cannabis sativa L. Smoke and Vapor (full–2009) https://www.jstage.jst.go.jp/article/cpb/58/2/58_2_201/_pdf
Cluster attacks responsive to recreational cannabis and dronabinol (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19220500
Tobacco-Related Health Costs: $800; Booze-Related Health Costs: $165; Pot-Related Health Costs: $20 – Any Questions? (news–2009) http://www.huffingtonpost.com/paul-armentano/tobacco-related-health-co_b_362539.html
top
Cannabis, Tobacco and Alcohol Use in Canada (news–2009) http://www.heretohelp.bc.ca/visions/cannabis-vol5/cannabis-tobacco-and-alcohol-use-in-canada


SOCIAL ADJUSTMENT / BEHAVIOR
Effects of THC on Behavioral Measures of Impulsivity in Humans (full–2003) http://www.nature.com/npp/journal/v28/n7/full/1300176a.html
Regulation of Cannabinoid CB1 Receptors in the Central Nervous System by Chronic Cannabinoids (abst–2003) http://dl.begellhouse.com/journals/7b004699754c9fe6,5aa33979065f2aa3,42019b6a7dd932fb.html
Cannabis Use Not Linked with Psychosocial Harm (news–2004) http://entheology.com/research/cannabis-use-not-linked-with-psychosocial-harm/
Using Marijuana in Adulthood: the Experience of a Sample of Users in Oklahoma City (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16537332
Cannabis, motivation, and life satisfaction in an internet sample (full–2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1435998/?tool=pmcentrez
Negative consequences associated with dependence in daily cannabis users (full-2007) http://www.substanceabusepolicy.com/content/2/1/3
Some go without a cigarette: characteristics of cannabis users who have never smoked tobacco (full-2007) http://archpedi.ama-assn.org/cgi/content/full/161/11/1042
Marijuana use motives and social anxiety among marijuana-using young adults (abst-2007) http://marijuana.researchtoday.net/archive/4/8/1303.htm
Teens who use only cannabis appear to function better than those who also use tobacco (news-2007) http://www.news-medical.net/news/2007/11/06/32262.aspx
Are Cigarettes More of a Drag on Teens than Marijuana? (news–2007) http://www.scientificamerican.com/article.cfm?id=are-cigarettes-more-of-a
Teens Who Smoke Marijuana But Not Tobacco Are Different From Other Teen Groups (news-2007) http://www.sciencedaily.com/releases/2007/11/071105164453.htm
Cannabinoid Modulation of Amygdala Reactivity to Social Signals of Threat in Humans (full–2008) http://www.jneurosci.org/cgi/content/full/28/10/2313?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT
Characteristics of Adolescents Who Use Cannabis But Not Tobacco (news–2008) http://forum.grasscity.com/general/884305-characteristics-adolescents-who-use-cannabis-but-nottobacco.html
Smokers of Cigarettes and Marijuana Fare Worse (news–2008) http://www.clinicalpsychiatrynews.com/index.php?id=2407&cHash=071010&tx_ttnews[tt_news]=38605
Relationship of type 1 cannabinoid receptor availability in the human brain to noveltyseeking temperament (full–2009) http://archpsyc.ama-assn.org/cgi/content/full/66/2/196
Decrease in Adolescent Cannabis Use From 2002 to 2006 and Links to Evenings Out With Friends in 31 European and North American Countries and Regions (full–2009) http://archpedi.jamanetwork.com/article.aspx?articleid=380833
Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19393686
top
Cannabis, Tobacco and Alcohol Use in Canada (news–2009) http://www.heretohelp.bc.ca/visions/cannabis-vol5/cannabis-tobacco-and-alcohol-use-in-canada
Why People Use Cannabis (news–2009) http://www.heretohelp.bc.ca/visions/cannabis-vol5/why-people-use-cannabis


SPASTICITY
Endocannabinoids control spasticity in a multiple sclerosis model (full–2000) http://tinyurl.com/6cnahu9
SCIENTIFIC STUDY HINTS AT MEDICAL BENEFITS IN CANNABINOIDS AND MULTIPLE SCLEROSIS (news–2000) http://www.alphagalileo.org/ViewItem.aspx?ItemId=52315&CultureCode=en
Cannabinoids in the treatment of pain and spasticity in multiple sclerosis (abst–2002) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=12137404&dopt=abstractplus
Therapeutic potential of cannabis (full–2003) http://www.ufcw770.org/sites/all/themes/danland/files/TherapeuticPotentialOfCannabis.pdf
Experiences with THC-treatment in children and adolescents (abst-2003) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=80
The treatment of spasticity with D9-tetrahydrocannabinol (D9-THC) in patients with spinal cord injury (abst–2003) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=79
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients (abst–2004) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=56
Are oral cannabinoids safe and effective in refractory neuropathic pain? (abst–2004) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=143
Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy. Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study (abst–2004) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=63
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/14744610
CB1 cannabinoid receptor-mediated modulation of food intake in mice (full–2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576140/?tool=pmcentrez
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up (abst–2005) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=160
Cannabis-based medicinal extract (Sativex) produced significant improvements in a subjective measure of spasticity which were maintained on long-term treatment with no evidence of tolerance (abst–2005) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=170
The treatment of spasticity with Delta(9)-tetrahydrocannabinol in persons with spinal cord injury (abst–2006) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=166
Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : A double-blind placebo-controlled cross-over trial (abst-2006) http://www.unboundmedicine.com/medline/ebm/record/16988792/abstract/Low_dose_treatment_with_the_synthetic_cannabinoid_Nabilone_significantly_reduces_spasticity_related_pain_:_A_double_blind_placebo_controlled_cross_over_trial_
top
Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/17086911
Control of Spasticity in a Multiple Sclerosis Model is mediated by CB1, not CB2, Cannabinoid Receptors (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189718/?tool=pmcentrez
Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis (abst-2007) (needs free registration) http://www.medscape.com/medline/abstract/17355549
Motor effects of delta 9 THC in cerebellar Lurcher mutant mice (abst–2007) http://www.unboundmedicine.com/medline/ebm/record/17531329/abstract/Motor_effects_of_delta_9_THC_in_cerebellar_Lurcher_mutant_mice
Cannabinoids in the management of spasticity associated with multiple sclerosis (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626929/?tool=pmcentrez
Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2793241/
Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain (full–2009) http://www.molecularpain.com/content/5/1/35
Marijuana Eases Spasticity in MS Patients (news–2009) http://www.webmd.com/multiple-sclerosis/news/20091204/marijuana-eases-spasticity-in-ms-patients
Medical Marijuana and Skeletal Muscular Spasticity (news–2009) https://www.marijuanadoctors.com/content/ailments/view/120?ailment=skeletal-muscular-spasticity
Marijuana Chemicals Ease MS Symptoms, Review Confirms (news–2009) http://www.drugfree.org/uncategorized/marijuana-chemicals-ease-ms
Cannabis can reduce spasticity in MS patients (news–2009) http://www.news-medical.net/news/20091204/Cannabis-can-reduce-spasticity-in-MS-patients.aspx
Medical Marijuana and Spasticity (news–2009) https://www.marijuanadoctors.com/content/ailments/view/119?ailment=spasticity


SPINAL CORD INJURY
A step closer to cannabinoids for pain relief (news–2000) http://www.alphagalileo.org/ViewItem.aspx?ItemId=51631&CultureCode=en
Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo (full–2001) http://jn.physiology.org/content/86/6/3061.long
Clinical investigation of delta-9-tetrahydrocannabinol (THC) as an alternative therapy for overactive bladders in spinal cord injury (SCI) patients (abst–2001) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=102
The treatment of spasticity with D9-tetrahydrocannabinol (D9-THC) in patients with spinal cord injury (abst–2003) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=79
Therapeutic potential of cannabinoids in CNS disease (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12617697
Are oral cannabinoids safe and effective in refractory neuropathic pain? (abst–2004) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=143
top
Interaction between gamma-aminobutyric acid GABAB and cannabinoid CB1 receptors in spinal pain pathways in rat (abst–2005) http://www.sciencedirect.com/science/article/pii/S0014299905003870
Treatments for Chronic Pain in Persons With Spinal Cord Injury: A Survey Study (full-2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1864800/?tool=pmcentrez
Antinociceptive effect of cannabinoid agonist WIN 55,212–2 in rats with a spinal cord injury (full-2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1861843/?tool=pmcentrez
Effects of a Cannabinoid Agonist on Spinal Nociceptive Neurons in a Rodent Model of Neuropathic Pain (full-2006) http://jn.physiology.org/cgi/content/full/96/6/2984
Cannabinoids In Medicine: A Review Of Their Therapeutic Potential (full–2006) http://www.doctordeluca.com/Library/WOD/WPS3-MedMj/CannabinoidsMedMetaAnalysis06.pdf
The treatment of spasticity with Delta(9)-tetrahydrocannabinol in persons with spinal cord injury (abst–2006) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=166
Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury (full–2008) http://jpet.aspetjournals.org/content/326/1/12.long
SUPPORTING RESEARCH INTO THE THERAPEUTIC ROLE OF MARIJUANA (full–2008) https://www.acponline.org/acp_policy/policies/supporting_medmarijuana_2008.pdf
Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743245/?tool=pmcentrez
The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function (abst–2009) http://content.karger.com/produktedb/produkte.asp?DOI=000201556&typ=pdf
Medical Marijuana and Whiplash (news–2009) https://www.marijuanadoctors.com/content/ailments/view/97?ailment=whiplash-


SPLEEN
Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo (full–2002) http://jpet.aspetjournals.org/content/302/2/451.long
A Cyclooxygenase Metabolite of Anandamide Causes Inhibition of Interleukin-2 Secretion in Murine Splenocytes (full–2004) http://jpet.aspetjournals.org/content/311/2/683.full
Pharmacokinetics of cannabinoids (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16237477


STEM CELLS
Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1919431/?tool=pubmed
CB2 cannabinoid receptors promote mouse neural stem cell proliferation (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17328768
top


STIFF-PERSON SYNDROME / HYPEREKPLEXIA DISEASE
Cures, Not Wars, Chant Supporters of Legalizing Marijuana (news/anecdotal–2004) http://cannabisnews.com/news/18/thread18778.shtml


STRESS
Cannabinoid CB1-mediated inhibition of stress-induced gastric ulcers in rats (abst–2000) http://www.springerlink.com/content/w3jc8rk16k9p92fl/
Endogenous Cannabinoids Take the Edge off Neuroendocrine Responses to Stress (full–2004) http://press.endocrine.org/doi/full/10.1210/en.2004-1218
Synergistic Interactions between Cannabinoids and Environmental Stress in the Activation of the Central Amygdala (full–2005) http://www.nature.com/npp/journal/v30/n3/full/1300535a.html
Body’s Own Marijuana-Like Compounds Are Crucial For Stress-Induced Pain Relief (news-2005) http://www.sciencedaily.com/releases/2005/06/050628064435.htm
Endocannabinoids — The Brain’s Cannabis — Demonstrate Novel Modes Of Action To Stress (news-2005) http://www.sciencedaily.com/releases/2005/07/050720065810.htm
Regulation of adult neurogenesis by cannabinoids (abst–2006) http://cat.inist.fr/?aModele=afficheN&cpsidt=18227851
Endocannabinoids Mediate the Effects of Acute Stress and Corticosterone on Sex Behavior (full–2007) http://endo.endojournals.org/content/148/2/493.full
Association of the Cannabinoid Receptor Gene (CNR1) With ADHD and Post-Traumatic Stress Disorder (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685476/?tool=pubmed
Endocannabinoids: Stress, Anxiety, and Fear (full–2009) http://neuro.psychiatryonline.org/article.aspx?articleid=103676&resultClick=3
Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716432/?tool=pubmed
Cannabinoid Receptor Activation in the Basolateral Amygdala Blocks the Effects of Stress on the Conditioning and Extinction of Inhibitory Avoidance (full–2009) http://www.jneurosci.org/cgi/content/full/29/36/11078?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=Dr.+Irit+Akirav+&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT
Voluntary Exercise and Sucrose Consumption Enhance Cannabinoid CB1 Receptor Sensitivity in the Striatum (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055381/?tool=pubmed
Chronic stress differentially regulates cannabinoid CB1 receptor binding in distinct hippocampal subfields (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746437/
Effects of {Delta}9-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress (abst–2009) http://www.unboundmedicine.com/medline/ebm/record/19406854/abstract/Effects_of_%7BDelta%7D9_tetrahydrocannabinol_on_reward_and_anxiety_in_rats_exposed_to_chronic_unpredictable_stress_
Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects (abst–2009) http://www.frontiersin.org/publications/19027757
top


STORAGE OF CANNABIS
Storing Medical Cannabis (news–undated) http://www.harborsidehealthcenter.com/learn/storing-medical-cannabis.html
The stability of cannabis and its preparations on storage (abst–1976) http://www.ncbi.nlm.nih.gov/pubmed/6643
The decomposition of acidic and neutral cannabinoids in organic solvents (abst–1977) http://www.ncbi.nlm.nih.gov/pubmed/17692
Constituents of Cannabis sativa L. XIII: Stability of dosage form prepared by impregnating synthetic (–)-delta 9-trans-tetrahydrocannabinol on placebo Cannabis plant material (abst–1978) http://www.ncbi.nlm.nih.gov/pubmed/660481
Stability of Cannabis sativa L. samples and their extracts, on prolonged storage in Delhi (abst–1978) http://www.ncbi.nlm.nih.gov/pubmed/258607
Stability of Cannabinoids in Dried Samples of Cannabis Dating from Around 1896-1905 (abst–1990) http://www.ncbi.nlm.nih.gov/pubmed/2314109


STROKE
Age dependent accumulation of N-acyl-ethanolamine phospholipids in ischemic rat brain. A (31)P NMR and enzyme activity study (full–2000) http://www.jlr.org/content/41/6/985.long
Control of the cell survival/death decision by cannabinoids (abst–2001) http://www.ncbi.nlm.nih.gov/pubmed/11269508
Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity (abst–2001) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&pageSize=10&index=12
Increased Severity of Stroke in CB1 Cannabinoid Receptor Knock-Out Mice (full–2002) http://www.jneurosci.org/cgi/content/full/22/22/9771?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=80&resourcetype=HWCIT#Top
Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210 (full-2003) http://stroke.ahajournals.org/cgi/reprint/34/8/2000
US Patent 6630507 – Cannabinoids as antioxidants and neuroprotectants (full–2003) (Assignee (owner)- the US GOVERNMENT!) http://www.google.com/patents/US6630507
Post-ischemic Treatment with Cannabidiol Prevents Electroencephalographic Flattening, Hyperlocomotion and Neuronal Injury in Gerbils (abst–2003) http://www.sciencedirect.com/science/article/pii/S030439400300569X
Therapeutic potential of cannabinoids in CNS disease (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12617697
Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15640760
Cannabidiol Prevents Cerebral Infarction Via a Serotonergic 5-Hydroxytryptamine1A Receptor–Dependent Mechanism (full–2005) http://stroke.ahajournals.org/cgi/content/full/36/5/1071
Medical marijuana: study shows that THC slows atherosclerosis (news–2005) http://thenexthurrah.typepad.com/the_next_hurrah/2005/04/medical_marijua.html
Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16864698
The CB1 Cannabinoid Receptor Mediates Excitotoxicity-induced Neural Progenitor Proliferation and Neurogenesis (full-2007) http://www.jbc.org/content/282/33/23892.full
top
Cannabinoid CB2 receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637559/?tool=pmcentrez
Δ9-Tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189998/?tool=pmcentrez
Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism (full–2007) http://www3.interscience.wiley.com/cgi-bin/fulltext/118484119/HTMLSTART
Delta(9)-tetrahydrocannabinol (Delta(9)-THC) prevents cerebral infarction via hypothalamic-independent hypothermia (abst–2007) http://www.unboundmedicine.com/medline/ebm/record/17289082/abstract/Delta_9__tetrahydrocannabinol__Delta_9__THC__prevents_cerebral_infarction_via_hypothalamic_independent_hypothermia
The endocannabinoid system and neurogenesis in health and disease (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17404371
Role of cannabinoids and endocannabinoids in cerebral ischemia (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2581413/?tool=pmcentrez
Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577828/
Cannabinoid receptors in acute and chronic complications of atherosclerosis (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219535/?tool=pmcentrez
Endocannabinoids and cannabinoid receptors in ischaemia–reperfusion injury and preconditioning (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219536/?tool=pmcentrez
Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18634812
Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18823959
Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855650/?tool=pubmed
Therapeutic time window of cannabidiol treatment on delayed ischemic damage via highmobility group box1-inhibiting mechanism (full–2009) https://www.jstage.jst.go.jp/article/bpb/32/9/32_9_1538/_pdf
Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system (full–2009) http://stroke.ahajournals.org/content/40/6/2157.long
Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death (full-2009) http://onlinelibrary.wiley.com/doi/10.1111/j.1742-4658.2008.06765.x/full
CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic / reperfusion injury (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319431/
top


STUTTERING
Marihuana and Stuttering (anecdotal–undated) http://rxmarijuana.com/shared_comments/stuttering.htm
Medical Marijuana and Stuttering (news–2009) https://www.marijuanadoctors.com/content/ailments/view/63?ailment=stuttering


SUICIDE
Cannabis and suicide: longitudinal study (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19949196
Cannabis use and deliberate self-harm in adolescence: a comparative analysis of associations in England and Norway (abst–2009) http://www.unboundmedicine.com/medline/ebm/record/19813111/abstract/Cannabis_use_and_deliberate_self_harm_in_adolescence:_a_comparative_analysis_of_associations_in_England_and_Norway